Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - FENNEC PHARMACEUTICALS INC. | tv488216_10k.htm |
| EX-31.1 - EXHIBIT 31.1 - FENNEC PHARMACEUTICALS INC. | tv488216_ex31-1.htm |
| EX-99.1 - EXHIBIT 99.1 - FENNEC PHARMACEUTICALS INC. | tv488216_ex99-1.htm |
| EX-32.1 - EXHIBIT 32.1 - FENNEC PHARMACEUTICALS INC. | tv488216_ex32-1.htm |
| EX-23.2 - EXHIBIT 23.2 - FENNEC PHARMACEUTICALS INC. | tv488216_ex23-2.htm |
| EX-31.2 - EXHIBIT 31.2 - FENNEC PHARMACEUTICALS INC. | tv488216_ex31-2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (file no. 333-221091) and S-3 (file no. 333-221093) of Fennec Pharmaceuticals Inc. (the “Company”) of our report dated March 28, 2018 relating to the consolidated financial statements, which appear in the Annual Report on Form 10-K for the year ended December 31, 2017.
/s/ HASKELL & WHITE LLP
Irvine, California
March 28, 2018